Scalper1 News
Cantor Fitzgerald on Thursday downgraded Endo Health Solutions (ENDP) to sell, sending shares down more than 2% in the stock market today. Analyst Irina Rivkind wrote in a research note that the company probably won’t be able to make further cost cuts unless it sells its American Medical Systems unit, and that upcoming drug launches will face stiff competition. She was particularly negative on the migrain patch Zecuity, which Endo will acquire Scalper1 News
Scalper1 News